{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:13:19Z","timestamp":1779167599894,"version":"3.51.4"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors with metastatic potential. Both <jats:sup>68<\/jats:sup>Ga-DOTATATE and <jats:sup>18<\/jats:sup>F-FDG PET\/CT scans have been demonstrated to have important roles in imaging PPGLs, but less is known about the performance of PET\/MRI for PPGLs. The study is aimed to investigate whether diffusion-weighted imaging\u2013MRI (DWI-MRI) has an added value to PET imaging in the identification of PPGL lesions by means of integrated PET\/MRI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Eleven patients who underwent both <jats:sup>18<\/jats:sup>F-FDG and <jats:sup>68<\/jats:sup>Ga-DOTATATE PET\/MRI within 2 weeks were retrospectively included in the study. A total of 56 PPGL lesions were analyzed, and lesion-based detection rates of <jats:sup>68<\/jats:sup>Ga-DOTATATE PET, <jats:sup>18<\/jats:sup>F-FDG PET, DWI-MRI, and PET\/MRI were calculated and compared, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>\n                                 <jats:sup>68<\/jats:sup>Ga-DOTATATE PET was superior to <jats:sup>18<\/jats:sup>F-FDG PET and DWI-MRI in imaging PPGLs with a lesion-based detection rate of 96.4% (54\/56) (95% confidence interval [CI], 87.7%\u201399.6%), 85.7% (48\/56) (95% CI, 76.3%\u201395.2%), and 89.3% (50\/56) (95% CI, 80.9%\u201397.6%), respectively. PET\/MRI with DWI could improve the detection rate of <jats:sup>68<\/jats:sup>Ga-DOTATATE and <jats:sup>18<\/jats:sup>F-FDG PET alone up to 100% in metastatic PPGLs. Lesions of PPGL demonstrated markedly higher tracer uptake in <jats:sup>68<\/jats:sup>Ga-DOTATATE PET than in <jats:sup>18<\/jats:sup>F-FDG PET (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.009 for primary lesion, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.033 for metastases).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>\n                                 <jats:sup>68<\/jats:sup>Ga-DOTATATE PET showed a higher detection rate than <jats:sup>18<\/jats:sup>F-FDG for PPGLs. In integrated PET\/MRI, MRI had an added value to <jats:sup>18<\/jats:sup>F-FDG PET but not much to <jats:sup>68<\/jats:sup>Ga-DOTATATAE PET in identifying PPGL lesions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000004077","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T18:06:50Z","timestamp":1644516410000},"page":"299-304","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Integrated PET\/MRI With 68Ga-DOTATATE and 18F-FDG in Pheochromocytomas and Paragangliomas"],"prefix":"10.1097","volume":"47","author":[{"given":"Si","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinxin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijun","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,2,8]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMra1806651","article-title":"Pheochromocytoma and paraganglioma","volume":"381","year":"2019","journal-title":"N Engl J Med"},{"key":"bib2-20250621","first-page":"58","article-title":"Pheochromocytoma and paraganglioma: current functional and future molecular imaging","volume":"1","year":"2011","journal-title":"Front Oncol"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/eci.12495","article-title":"Metastatic pheochromocytoma and paraganglioma","volume":"45","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/er.2017-00062","article-title":"New perspectives on pheochromocytoma and paraganglioma: toward a molecular classification","volume":"38","year":"2017","journal-title":"Endocr Rev"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1530\/ERC-10-0175","article-title":"Expression of somatostatin receptors, dopamine D2 receptors, noradrenaline transporters, and vesicular monoamine transporters in 52 pheochromocytomas and paragangliomas","volume":"18","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2967\/jnumed.118.211706","article-title":"Performance of 68Ga-DOTA\u2013conjugated somatostatin receptor\u2013targeting peptide PET in detection of pheochromocytoma and paraganglioma: a systematic review and metaanalysis","volume":"60","year":"2019","journal-title":"J Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"R627","DOI":"10.1530\/ERC-19-0165","article-title":"Molecular imaging and radionuclide therapy of pheochromocytoma and paraganglioma in the era of genomic characterization of disease subgroups","volume":"26","year":"2019","journal-title":"Endocr Relat Cancer"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/cen.14375","article-title":"PET detectives: molecular imaging for phaeochromocytomas and paragangliomas in the genomics era","volume":"95","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"420","DOI":"10.2967\/jnumed.115.158808","article-title":"18F-FDG PET\/CT and PET\/MRI perform equally well in cancer: evidence from studies on more than 2,300 patients","volume":"57","year":"2016","journal-title":"J Nucl Med"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/jmri.25711","article-title":"PET\/MRI: where might it replace PET\/CT?","volume":"46","year":"2017","journal-title":"J Magn Reson Imaging"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/cen.13980","article-title":"Diffusion-weighted imaging (DWI) highlights SDHB-related tumours: a pilot study","volume":"91","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1158\/1078-0432.CCR-15-1576","article-title":"In vivo detection of succinate by magnetic resonance spectroscopy as a hallmark of SDHx mutations in paraganglioma","volume":"22","year":"2016","journal-title":"Clin Cancer Res"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1158\/0008-5472.CAN-18-0125","article-title":"LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity","volume":"78","year":"2018","journal-title":"Cancer Res"},{"key":"bib14-20250621","first-page":"1342","article-title":"Comparison of different methods for delineation of 18F-FDG PET\u2013positive tissue for target volume definition in radiotherapy of patients with non\u2013small cell lung cancer","volume":"46","year":"2005","journal-title":"J Nucl Med"},{"key":"bib15-20250621","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1007\/s00259-019-04455-9","article-title":"Prognostic value of somatostatin receptor expressing tumor volume calculated from 68Ga-DOTATATE PET\/CT in patients with well-differentiated neuroendocrine tumors","volume":"46","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib16-20250621","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2214\/AJR.15.15318","article-title":"Comparison of quantitative MRI and CT washout analysis for differentiation of adrenal pheochromocytoma from adrenal adenoma","volume":"206","year":"2016","journal-title":"Am J Roentgenol"},{"key":"bib17-20250621","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2967\/jnumed.108.060731","article-title":"18F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature?","volume":"50","year":"2009","journal-title":"J Nucl Med"},{"key":"bib18-20250621","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.2967\/jnumed.111.091165","article-title":"68Ga-DOTATOC versus 68Ga-DOTATATE PET\/CT in functional imaging of neuroendocrine tumors","volume":"52","year":"2011","journal-title":"J Nucl Med"},{"key":"bib19-20250621","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1158\/1078-0432.CCR-14-2751","article-title":"Superiority of 68Ga-DOTATATE PET\/CT to other functional imaging modalities in the localization of SDHB-associated metastatic pheochromocytoma and paraganglioma","volume":"21","year":"2015","journal-title":"Clin Cancer Res"},{"key":"bib20-20250621","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00259-017-3896-9","article-title":"Superiority of 68Ga-DOTATATE over 18F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx)\u2013related pheochromocytoma and paraganglioma in the pediatric population","volume":"45","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib21-20250621","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2967\/jnumed.115.161018","article-title":"68Ga-DOTATATE PET\/CT in the localization of head and neck paragangliomas compared with other functional imaging modalities and CT\/MRI","volume":"57","year":"2016","journal-title":"J Nucl Med"},{"key":"bib22-20250621","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1177\/0284185118764206","article-title":"68Ga-somatostatin receptor analogs and 18F-FDG PET\/CT in the localization of metastatic pheochromocytomas and paragangliomas with germline mutations: a meta-analysis","volume":"59","year":"2018","journal-title":"Acta Radiol"},{"key":"bib23-20250621","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.3390\/cancers12092424","article-title":"Usefulness of FDG-PET\/CT\u2013based radiomics for the characterization and genetic orientation of pheochromocytomas before surgery","volume":"12","year":"2020","journal-title":"Cancer"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:06:03Z","timestamp":1750536363000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004077"}},"subtitle":["An Initial Study"],"short-title":[],"issued":{"date-parts":[[2022,2,8]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004077","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,8]]}}}